BSECompany UpdateResults3d ago
Eiko Lifesciences Ltd
Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, The copy of newspaper publication in the following ....
Eiko Lifesciences Ltd has published its unaudited financial results for the quarter ended 30th June, 2026, as approved by the Board of Directors on 12th August, 2026.
BSEBoard MeetingResults4d ago
Eiko Lifesciences Ltd
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments ....
Eiko Lifesciences Ltd has announced its un-audited standalone and consolidated financial results for the quarter ended 30th June, 2026, along with a limited review report issued by its statutory auditors.
BSEBoard MeetingResults7 Aug 2026
Eiko Lifesciences Ltd
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve The Unaudited Standalone ....
Eiko Lifesciences Ltd has scheduled a board meeting on 12th August 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.